Cost-utility estimates in depression: Does the valuation method matter?

Journal of Mental Health Policy and Economics

Volumn 13, Issue 4, 2010, Pages 189-197

  Jonkers, Catharina C M ^a   Lamers, Femke ^a   Evers, Silvia M A A ^a   Bosma, Hans ^a   Van Eijk, Jacques Th M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECK DEPRESSION INVENTORY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; GERIATRIC CARE; HUMAN; INSTRUMENT VALIDATION; MAJOR DEPRESSION; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR;

AGED; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650451030     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Donohue JM, Pincus HA. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. Pharmacoeconomics 2007;25(1):7-24.
2. Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in communitydwelling older persons. JAMA 1998;279(21):1720-1726.
3. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV, 3rd, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 1995;274(19):1511-1517.
4. Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999;56(10):889-895.
5. Katz IR. On the inseparability of mental and physical health in aged persons: Lessons from depression and medical comorbidity. Am J Geriatr Psychiatry 1996;4(1):1-16.
6. Katon WJ, Lin E, Russo J, Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry 2003;60(9):897-903.
7. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res 2003;12(1):22-33.
8. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press; 2007.
9. Drummond MF. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press; 1997.
10. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
11. Chisholm D, Healey A, Knapp M. QALYs and mental health care. Soc Psychiatry Psychiatr Epidemiol 1997;32(2):68-75.
12. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118(8):622-629.
13. Pyne JM, Tripathi S, Williams DK, Fortney J. Depression-free day to utility-weighted score: is it valid? Med Care 2007;45(4):357-362.
14. Donald Sherbourne C, Unutzer J, Schoenbaum M, Duan N, Lenert LA, Sturm R, et al. Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Med Care. 2001;39(11):1246-1259.
15. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993;13(2):89-102.
16. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978;31(11):697-704.
17. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982;30(6):1043-1069.
18. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999;56(10):897-904.
19. Bennett KJ, Torrance GW, Boyle MH, Guscott R, Moran LA. Development and testing of a utility measure for major, unipolar depression (McSad). Qual Life Res 2000;9(1):109-120.
20. Hatziandreu EJ, Brown RE, Revicki DA, Turner R, Martindale J, Levine S, Siegel JE. Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. Pharmacoeconomics 1994;5(3):249-268.
21. Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord 1998;48(1):25-36.
22. Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Utility scores of symptom profiles in major depression. Psychiatry Res 2002;110(2):189-197.
23. EuroQol G. EuroQol-a new facility for the measurement of healthrelated quality of life. The EuroQol Group. Health Policy. 1990;16(3):199-208.
24. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995;7(6):503-520.
25. Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988;23(2):203-235.
26. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preferencebased single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998;51(11):1115-1128.
27. McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 2007;25(2):93-106.
28. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271-292.
29. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35(11):1095-1108.
30. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995;7(6):490-502.
31. Pyne JM, Rost KM, Zhang M, Williams DK, Smith J, Fortney J. Costeffectiveness of a primary care depression intervention. J Gen Intern Med 2003;18(6):432-441.
32. van Roijen LH, van Straten A, Al M, Rutten F, Donker M. Cost-utility of brief psychological treatment for depression and anxiety. Br J Psychiatry 2006;188:323-329.
33. Schoenbaum M, Unutzer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA. 2001;286(11):1325- 1330.
34. Jonkers CC, Lamers F, Evers SM, Bosma H, Metsemakers JF, Van Eijk JT. Economic evaluation of a minimal psychological intervention in chronically ill elderly patients with minor or mild to moderate depression: a randomized trial (the DELTA-study). Int J Technol Assess Health Care 2009;25(4):497-504.
35. Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 2006;15(11):1229-1236.
36. Sapin C, Fantino B, Nowicki ML, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2004;2:20.
37. Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Martensson B, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health 2007;10(2):153-160.
38. Bennett KJ, Torrance GW, Boyle MH, Guscott R. Cost-utility analysis in depression: the McSad utility measure for depression health states. Psychiatr Serv 2000;51(9):1171-1176.
39. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 1974;7(0):79-110.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
41. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Rev 1988;8(1):77-100.
42. Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 1998;55(7):645-651.
43. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, et al. The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry 2002;59(7):605-611.
44. Kaplan RM. Health-Related Quality of Life in Mental Health Services Evaluation. New York: Oxford University Press; 1999.
45. Simon GE, Katon WJ, Lin EH, Rutter C, Manning WG, Von Korff M, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007;64(1):65-72.
46. Simon GE, Katon WJ, VonKorff M, Unutzer J, Lin EH, Walker EA, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry 2001;158(10):1638-1644.
47. Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 2001;58(2):181-187.
48. Simon GE, Von Korff M, Ludman EJ, Katon WJ, Rutter C, Unutzer J, et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Med Care 2002;40(10):941-950.
49. Katon WJ, Schoenbaum M, Fan MY, Callahan CM, Williams J, Jr., Hunkeler E, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry 2005;62(12):1313-1320.
50. Lynch FL, Hornbrook M, Clarke GN, Perrin N, Polen MR, O'Connor E, et al. Cost-effectiveness of an intervention to prevent depression in atrisk teens. Arch Gen Psychiatry 2005;62(11):1241-1248.
51. Lamers F, Jonkers CC, Bosma H, Kempen GI, Meijer JA, Penninx BW, et al. A Minimal Psychological Intervention in Chronically Ill Elderly Patients with Depression: A Randomized Trial. Psychother Psychosom 2010;79(4):217-226.
52. Lamers F, Jonkers CC, Bosma H, Diederiks JP, van Eijk JT. Effectiveness and cost-effectiveness of a minimal psychological intervention to reduce non-severe depression in chronically ill elderly patients: the design of a randomised controlled trial [ISRCTN92331982]. BMC Public Health 2006;6(1):161.
53. Van Eijk JT, Diederiks JP, Kempen GI, Honig A, van der Meer K, Brenninkmeijer WJ. Development and feasibility of a nurse administered strategy on depression in community-dwelling patients with a chronic physical disease. Patient Educ Couns 2004;54(1):87-94.
54. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
55. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006;15(10):1121-1132.
56. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E., Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51(11):1055-1068.
57. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300(6719):230-235.
58. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996;1(1):30-46.
59. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley; 1981.
60. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310.
61. Casparie AF, van Hout BA, Simoons ML. Richtlijnen en kosten [Guidelines and costs]. Ned Tijdschr Geneeskd 1998;142(38):2075-2077.
62. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med 2007;101(2):308-316.
63. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M. I. N. I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33.
64. Kopec JA, Willison KD. A comparative review of four preferenceweighted measures of health-related quality of life. J Clin Epidemiol 2003;56(4):317-325.
65. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13(9):873-884.